Bleomycin‐induced flagellate hyperpigmentation

A 27‐year old male with Hodgkin's lymphoma was treated with combined chemotherapy that included bleomycin. He presented with pruritic erythematous, edematous linear lesions and was diagnosed to have flagellate hyperpigmentation, a rare side effect of bleomycin chemotherapy.

Detalles Bibliográficos
Autores principales: Larson, Krista N., Gagnon, Amy L., Wilson, Barbara B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5378868/
https://www.ncbi.nlm.nih.gov/pubmed/28396762
http://dx.doi.org/10.1002/ccr3.831
Descripción
Sumario:A 27‐year old male with Hodgkin's lymphoma was treated with combined chemotherapy that included bleomycin. He presented with pruritic erythematous, edematous linear lesions and was diagnosed to have flagellate hyperpigmentation, a rare side effect of bleomycin chemotherapy.

Ejemplares similares